IL1B and COVID-19: Mitochondrial ROS mediate various signaling pathways, increase the expression of inflammatory cytokines (IL-6, IL-1β, TNF-α, etc.), and increase the risk of thrombosis in patients with COVID-19 [140] (Figure 4).